Atara Biotherapeutics Inc (NAS:ATRA)
$ 10.28 -1.35 (-11.61%) Market Cap: 58.33 Mil Enterprise Value: 83.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Q4 2019 Atara Biotherapeutics Inc Earnings Call Transcript

Feb 27, 2020 / 01:00PM GMT
Release Date Price: $287 (+2.78%)
Operator

Good morning, ladies and gentlemen, and welcome to the Atara Biotherapeutics Q4 and Full Year 2019 Financial Results Conference Call. (Operator Instructions).

I'd now like to turn the conference over to your host, Dr. John Craighead, Vice President of Investor Relations and Corporate Communications of Atara Biotherapeutics. Please go ahead.

John Craighead
Atara Biotherapeutics, Inc. - VP of IR & Corporate Communications

Thank you, operator. Good morning everyone, and welcome to Atara's fourth quarter and full year 2019 conference call. On today's call, we will provide an update of our clinical, operational and strategic progress, as well as a review of our upcoming milestones and key objectives for 2020.

Earlier this morning, we issued a press release providing an overview of the company's fourth quarter and full year 2019 financial results. This press release and an updated investor presentation are available in the Investor & Media section at atarabio.com.

Joining me on today's call are Dr. Pascal Touchon, President and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot